11:30 AM - 11:35 AM Industry Satellite Symposium Presentation ROCHE - Immunotherapy: The new standard of care for solid tumours Industry Satellite Symposium

• S. Dawood

05:15 PM - 05:45 PM ESMO Colloquium Presentation ESMO COLLOQUIUM - Oncology biosimilars in Asia ESMO Colloquium

12:45 PM - 12:50 PM Industry Satellite Symposium Presentation PFIZER ONCOLOGY - Making strides in the management of HR+ HER2- metastatic breast cancer Industry Satellite Symposium

• S. Lee

11:30 AM - 11:35 AM Industry Satellite Symposium Presentation MERCK - What are the treatment options for R/M SCCHN beyond immune check-point inhibitors? Industry Satellite Symposium

• T. Yokota

04:30 PM - 04:35 PM ESMO Colloquium Presentation ESMO COLLOQUIUM - Oncology biosimilars in Asia ESMO Colloquium

12:45 PM - 12:50 PM Industry Satellite Symposium Presentation ASTRAZENECA - DNA Damage response in ovarian and breast cancers: Promising evidence heralds new hope Industry Satellite Symposium

• M. Mastura

12:45 PM - 12:55 PM Industry Satellite Symposium Presentation IPSEN - Raising the bar in the management of patients with urological cancers Industry Satellite Symposium

• R. Kanesvaran

01:05 PM - 01:20 PM ESMO Colloquium Presentation ESMO COLLOQUIUM - Updated therapeutic approach of castration-resistant prostate cancer ESMO Colloquium

• B. Tran

12:45 PM - 12:50 PM Industry Satellite Symposium Presentation MSD - A quantum leap in lung and updates in H&N cancer treatment with immunotherapy Industry Satellite Symposium

• D. Tan

12:50 PM - 01:05 PM Industry Satellite Symposium Presentation PFIZER ONCOLOGY - Translating clinical evidence to real-world experience in NSCLC Industry Satellite Symposium

• P. Yang

09:50 AM - 10:00 AM ESMO Colloquium Presentation ESMO COLLOQUIUM - Metastatic gastric and oeso-gastric junction cancers ESMO Colloquium

• Y. Bang

12:50 PM - 01:15 PM Industry Satellite Symposium Presentation ASTRAZENECA - Right from the start: Putting evidence into practice in NSCLC Industry Satellite Symposium

• C. Karapetis